Home › Funds › Smead Capital Management, Inc. › CROX

Smead Capital Management, Inc. position in CROX

CROCS INC · Consumer Discretionary

Smead Capital Management, Inc. reported holding 709,816 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$83.3M, representing 1.77% of its reported portfolio and ranking #24 among its reported holdings. Smead Capital Management, Inc. has disclosed CROX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)709.82K sh
Reported value held$83.27M
Portfolio Weight1.77%
First reportedQ3 2025
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Smead Capital Management, Inc.'s CROX position evolved

Smead Capital Management, Inc. first disclosed a stake in CROX in Q3 2025 at 634,082 shares (US$53.0M). The position peaked in Q3 2026 at 709,816 shares, worth US$83.3M. Across 5 filings, Smead Capital Management, Inc. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 709,816 shares valued at US$83.3M — an increase of 220,571 shares quarter over quarter.. Notable position changes include a 45% increase in Q3 2026 (shares rose 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 634.08K $52.98M New
Q4 2025 594.69K $50.86M Reduce
Q1 2026 517.17K $42.94M Reduce
Q2 2026 489.25K $59.02M Reduce
Q3 2026 709.82K $83.27M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CROX and 13F data

CROX (CROCS INC) is a Consumer Discretionary company. 29 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Patient Capital Management, LLC (US$96.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CROX

All CROX fund holders →

FAQ

How long has Smead Capital Management, Inc. held CROX?

Smead Capital Management, Inc. has disclosed CROX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Smead Capital Management, Inc.'s current position in CROX?

As of Q3 2026, Smead Capital Management, Inc. holds 709.82K shares of CROX (CROCS INC), valued at $83.27M, representing 1.77% of its reported portfolio and ranking #24.

Has Smead Capital Management, Inc. been buying or selling CROX?

In the latest 13F filing (Q3 2026), Smead Capital Management, Inc. increased its position in CROX. The position peaked in Q3 2026 at 709.82K shares.

Which other funds hold CROX?

Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Patient Capital Management, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.